Gregory Strubbe, Eveline Van Honacker, Stien Vandendriessche, Anne-Sophie Messiaen, Bruno Verhasselt, Jerina Boelens
{"title":"在非自动化实验室环境中直接从阳性血液培养物进行 EUCAST 快速抗菌药物敏感性测试的验证。","authors":"Gregory Strubbe, Eveline Van Honacker, Stien Vandendriessche, Anne-Sophie Messiaen, Bruno Verhasselt, Jerina Boelens","doi":"10.1080/17843286.2024.2421075","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>To speed up antimicrobial susceptibility testing (AST), the European Committee on Antimicrobial Susceptibility Testing (EUCAST) proposed rapid AST (RAST), a disk diffusion method to be read after 4, 6 and 8 hours of incubation. We investigated the feasibility of implementation of RAST in a non-automated lab setting.</p><p><strong>Materials & methods: </strong>To this end, reference strains as well as a variety of clinical and resistant strains were used to spike sterile hemocultures (BioMérieux BACT/ALERT 3D® and Becton Dickinson BACTEC FX® systems), followed by RAST in comparison to classical long-incubation AST.</p><p><strong>Results & conclusion: </strong>Our results with reference strains show that reading RAST after 4 hours is frequently too soon to obtain clinical results, and that <i>Streptococcus pneumoniae</i> reference strain did yield readable inhibition zones in RAST when harvested from BioMérieux BACT/ALERT 3D® bottle cultures. In a wider panel of strains, Gram positives RAST results were very similar to standard AST, while with Gram negative species errors were more frequently observed, limiting clinical implementation.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":" ","pages":"1-8"},"PeriodicalIF":1.6000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validation of EUCAST rapid antimicrobial susceptibility testing directly from positive blood cultures in a non-automated lab setting.\",\"authors\":\"Gregory Strubbe, Eveline Van Honacker, Stien Vandendriessche, Anne-Sophie Messiaen, Bruno Verhasselt, Jerina Boelens\",\"doi\":\"10.1080/17843286.2024.2421075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>To speed up antimicrobial susceptibility testing (AST), the European Committee on Antimicrobial Susceptibility Testing (EUCAST) proposed rapid AST (RAST), a disk diffusion method to be read after 4, 6 and 8 hours of incubation. We investigated the feasibility of implementation of RAST in a non-automated lab setting.</p><p><strong>Materials & methods: </strong>To this end, reference strains as well as a variety of clinical and resistant strains were used to spike sterile hemocultures (BioMérieux BACT/ALERT 3D® and Becton Dickinson BACTEC FX® systems), followed by RAST in comparison to classical long-incubation AST.</p><p><strong>Results & conclusion: </strong>Our results with reference strains show that reading RAST after 4 hours is frequently too soon to obtain clinical results, and that <i>Streptococcus pneumoniae</i> reference strain did yield readable inhibition zones in RAST when harvested from BioMérieux BACT/ALERT 3D® bottle cultures. In a wider panel of strains, Gram positives RAST results were very similar to standard AST, while with Gram negative species errors were more frequently observed, limiting clinical implementation.</p>\",\"PeriodicalId\":7086,\"journal\":{\"name\":\"Acta Clinica Belgica\",\"volume\":\" \",\"pages\":\"1-8\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Clinica Belgica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17843286.2024.2421075\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Clinica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17843286.2024.2421075","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
简介:为了加快抗菌药物药敏试验(AST)的速度,欧洲抗菌药物药敏试验委员会(EUCAST)提出了快速抗菌药物药敏试验(RAST),这是一种在培养 4、6 和 8 小时后读取结果的磁盘扩散法。我们研究了在非自动化实验室环境中实施 RAST 的可行性:为此,我们使用参考菌株以及各种临床菌株和耐药菌株进行无菌血液培养(生物梅里埃 BACT/ALERT 3D® 和 Becton Dickinson BACTEC FX® 系统),然后使用 RAST 与传统的长孵育 AST 进行比较:我们对参考菌株的研究结果表明,4 小时后读取 RAST 往往太快,无法获得临床结果,而从生物梅里埃 BACT/ALERT 3D® 瓶培养物中提取的肺炎链球菌参考菌株在 RAST 中确实产生了可读取的抑制区。在更广泛的菌株中,革兰氏阳性菌的 RAST 结果与标准 AST 非常相似,而革兰氏阴性菌则经常出现误差,从而限制了临床应用。
Validation of EUCAST rapid antimicrobial susceptibility testing directly from positive blood cultures in a non-automated lab setting.
Introduction: To speed up antimicrobial susceptibility testing (AST), the European Committee on Antimicrobial Susceptibility Testing (EUCAST) proposed rapid AST (RAST), a disk diffusion method to be read after 4, 6 and 8 hours of incubation. We investigated the feasibility of implementation of RAST in a non-automated lab setting.
Materials & methods: To this end, reference strains as well as a variety of clinical and resistant strains were used to spike sterile hemocultures (BioMérieux BACT/ALERT 3D® and Becton Dickinson BACTEC FX® systems), followed by RAST in comparison to classical long-incubation AST.
Results & conclusion: Our results with reference strains show that reading RAST after 4 hours is frequently too soon to obtain clinical results, and that Streptococcus pneumoniae reference strain did yield readable inhibition zones in RAST when harvested from BioMérieux BACT/ALERT 3D® bottle cultures. In a wider panel of strains, Gram positives RAST results were very similar to standard AST, while with Gram negative species errors were more frequently observed, limiting clinical implementation.
期刊介绍:
Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine primarily publishes papers on clinical medicine, clinical chemistry, pathology and molecular biology, provided they describe results which contribute to our understanding of clinical problems or describe new methods applicable to clinical investigation. Readership includes physicians, pathologists, pharmacists and physicians working in non-academic and academic hospitals, practicing internal medicine and its subspecialties.